Solexa and Collaborating Scientists Illuminate the Small RNA Component of the Transcriptome
News Sep 16, 2005
Solexa, Inc. has announced that its researchers, in collaboration with the Delaware Biotechnology Institute and the University of Delaware, reported the comprehensive analysis to date of the small RNA component of the transcriptome.
The research, "Elucidation of the Small RNA Component of the Transcriptome," was published in the September 2, 2005, issue of the peer-reviewed journal "Science."
Solexa's assay can be used to elucidate small RNAs in any plant or animal species, notably humans.
"Finding that small RNAs comprise a potent set of regulatory molecules in diverse organisms is among the most important discoveries in the past 10 years," stated John West, Solexa's chief executive officer.
"This research is pioneering in its ability to characterize these important regulatory molecules on a genome-wide scale."
Solexa claims that, its technology has the advantage of producing accurate, reproducible and quantitative readouts of the full complement of activated genes and small RNAs, including genes expressed at low levels, without requiring advance knowledge of the genes or sequences of interest.
The Company also intends to develop this small RNA assay for use with its next-generation sequencing platform, which is scheduled to be introduced to the market by the end of this year.
Using Solexa's high-throughput sequencing technology, the study identified over 77,000 small RNAs in Arabidopsis plants, 10 times more than previously known.
This study generated two million short DNA sequences, known as signature sequences or sequence tags, to identify and quantify both known and novel small RNA molecules.
Many regions of the Arabidopsis genome previously considered to be inactive or featureless were found to be sites of considerable small RNA activity.
"The signature sequencing approach makes possible the study of global identity, regulation and function of small RNA populations in diverse organisms,” said Blake Meyers, an Assistant Professor at the University of Delaware and a senior author on the study.
“This extensive small RNA data will help biologists understand small RNAs and their regulation."
"We have also released an enhanced version of our Arabidopsis MPSS website to further facilitate public access and use of these data."
"These experiments underscore the importance of studying the entire genome for evidence of small RNA activity,” said Pamela J. Green, a professor at the University of Delaware and the Delaware Biotechnology Institute, another senior author on the study.
“The newly discovered small RNAs that match to genes are exciting, but so are those that derive from relatively featureless regions between genes."
As genome editing technologies advance toward clinical therapies, they are raising hopes of a completely new way to treat disease. However, challenges need to be addressed before potential treatments can be widely used in patients. To tackle these challenges, the National Institutes of Health has launched the Somatic Cell Genome Editing program, which has awarded multiple grants including more than $3.6 million to assess the safety of genome editing in human cells and tissues.